Cytokinetics, Inc. (CYTK)
62.02
-0.14
(-0.23%)
USD |
NASDAQ |
Dec 16, 16:00
61.61
-0.41
(-0.66%)
After-Hours: 07:03
Cytokinetics Research and Development Expense (Annual): 329.88M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Jasper Therapeutics, Inc. | 57.31M |
| Bristol Myers Squibb Co. | 9.782B |
| Lantheus Holdings, Inc. | 168.10M |
| Pfizer Inc. | 10.74B |
| Fortrea Holdings, Inc. | -- |